Neurodegenerative Disease

Investigating how soluble, oligomeric forms of Aβ can modulate novel cellular mechanisms that mediate neuronal and network-level excitability.

Researching the molecular mechanisms involved in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Studying mild cognitive impairment, which is a precursor to Alzheimer’s disease (AD), Down syndrome, and traumatic brain injury (TBI).

Exploring the cellular and molecular mechanisms of neurodegeneration in central nervous system disorders such as amyotrophic lateral sclerosis and frontotemporal dementia

Translating findings in human patient samples into improved drug therapies for ALS patients.